As Big Pharma Stock Soars, Third FDA Adviser Resigns Over Approval of Alzheimer’s Drug

The doctor and panel member wrote that it “was probably the worst drug approval decision in recent U.S. history.”

This post was originally published on Common Dreams – Breaking News & Views for the Progressive Community.